RCUS

Arcus Biosciences, Inc.NYSEHealthcare

$22.96-3.14%ClosedMarket Cap: $2.31B

As of 2026-04-06

Recent Analyst Ratings

Date	Firm	Action	Rating	Previous
2026-04-02	Wedbush	—	Outperform	—
2026-03-05	Citigroup	—	Buy	—
2026-03-02	HC Wainwright & Co.	—	Buy	—
2026-03-02	Leerink Partners	—	Outperform	—
2026-02-12	Wells Fargo	—	Equal Weight	—
2026-01-13	Goldman Sachs	—	Buy	—
2026-01-08	Morgan Stanley	—	Equal Weight	—
2025-12-12	HC Wainwright & Co.	—	Buy	—
2025-11-28	B of A Securities	—	Neutral	—
2025-10-30	Goldman Sachs	—	Neutral	—

Forward Estimates

Period	EPS Est.	Revenue Est.	# Analysts
Fri Dec 31	$-3.34	$111.6M	6
Sun Dec 31	$-2.19	$195.7M	8
Mon Dec 31	$-0.77	$453.9M	6
Tue Dec 31	$1.70	$946.6M	6